Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 20,782,487
- Share change
- +268,724
- Total reported value
- $1,364,495,044
- Put/Call ratio
- 36%
- Price per share
- $65.66
- Number of holders
- 129
- Value change
- +$17,501,639
- Number of buys
- 61
- Number of sells
- 62
Report period
Q2 2022
Institutions
129
Top holders
10
KRYS full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501147102
Recent filing periods:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
7.1%
|
2,106,487
|
$140,166,000 | — | 31 Mar 2022 | |
| Redmile Group, LLC |
13F
|
Company |
6.2%
|
1,815,698
|
$120,817,000 | — | 31 Mar 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
5.8%
|
1,720,267
|
$114,467,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.7%
|
1,683,511
|
$112,020,000 | — | 31 Mar 2022 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
4%
|
1,178,813
|
$78,438,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.6%
|
1,068,656
|
$71,108,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,051,445
|
$69,964,000 | — | 31 Mar 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.4%
|
1,005,000
|
$66,873,000 | — | 31 Mar 2022 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.9%
|
866,250
|
$57,640,000 | — | 31 Mar 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.7%
|
807,735
|
$53,747,000 | — | 31 Mar 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.6%
|
757,857
|
$50,427,000 | — | 31 Mar 2022 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.4%
|
717,936
|
$47,771,000 | — | 31 Mar 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
2.3%
|
688,555
|
$45,816,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
1.7%
|
500,000
|
$33,270,000 | — | 31 Mar 2022 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.3%
|
384,810
|
$25,605,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
365,290
|
$24,306,000 | — | 31 Mar 2022 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.98%
|
289,337
|
$19,252,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.89%
|
262,463
|
$17,465,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.88%
|
257,861
|
$17,158,000 | — | 31 Mar 2022 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.78%
|
228,732
|
$15,220,000 | — | 31 Mar 2022 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.77%
|
225,809
|
$15,025,000 | — | 31 Mar 2022 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.71%
|
208,711
|
$13,888,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
194,102
|
$12,915,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
148,347
|
$9,872,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.46%
|
136,047
|
$9,053,000 | — | 31 Mar 2022 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.37%
|
110,000
|
$7,319,000 | — | 31 Mar 2022 | |
| S SQUARED TECHNOLOGY, LLC |
13F
|
Company |
0.37%
|
108,215
|
$7,201,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
86,895
|
$5,782,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.29%
|
84,259
|
$5,644,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
71,975
|
$4,788,000 | — | 31 Mar 2022 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.23%
|
68,309
|
$4,545,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.2%
|
60,012
|
$3,993,000 | — | 31 Mar 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
59,000
|
$3,926,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
58,070
|
$3,864,000 | — | 31 Mar 2022 | |
| CWM, LLC |
13F
|
Company |
0.18%
|
52,303
|
$3,480,000 | — | 31 Mar 2022 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
46,489
|
$3,093,000 | — | 31 Mar 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.15%
|
45,000
|
$1,106,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
42,586
|
$2,834,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.14%
|
41,200
|
$2,741,000 | — | 31 Mar 2022 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.13%
|
39,101
|
$2,602,000 | — | 31 Mar 2022 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.13%
|
37,070
|
$2,467,000 | — | 31 Mar 2022 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.12%
|
34,242
|
$2,278,000 | — | 31 Mar 2022 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.11%
|
33,878
|
$2,254,000 | — | 31 Mar 2022 | |
| J. Goldman & Co LP |
13F
|
Company |
0.11%
|
31,859
|
$2,120,000 | — | 31 Mar 2022 | |
| Verition Fund Management LLC |
13F
|
Company |
0.11%
|
31,166
|
$2,074,000 | — | 31 Mar 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.1%
|
29,880
|
$1,988,000 | — | 31 Mar 2022 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
28,980
|
$1,928,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.09%
|
27,066
|
$1,801,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.09%
|
25,913
|
$1,724,000 | — | 31 Mar 2022 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.09%
|
25,788
|
$1,716,000 | — | 31 Mar 2022 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q2 2022
As of 30 Jun 2022,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,782,487 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, BlackRock Inc., Point72 Asset Management, L.P., LORD, ABBETT & CO. LLC, Frazier Life Sciences Management, L.P., Avoro Capital Advisors LLC, VANGUARD GROUP INC, STATE STREET CORP, and BAKER BROS. ADVISORS LP.
This page lists
129
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
129
Q2 2022 holders
129
Holder diff
0
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.